Craniopharyngioma clinical trials at UCSF
1 research study open to eligible people
Craniopharyngioma is a tumor located near the brain’s pituitary gland. UCSF is conducting research to test Tovorafenib for its ability to treat these tumors in younger patients. The study will explore how well participants tolerate this treatment and how effective it is in managing the tumor.
Showing trials for
Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults
open to eligible people ages 1-39
The current study assesses the tolerability and efficacy of monotherapy with pan-RAF-kinase (Tovorafenib) inhibition for the treatment of children and young adults with craniopharyngioma.
San Francisco, California and other locations
Our lead scientists for Craniopharyngioma research studies include Sabine Mueller, MD, PhD, MAS.
Last updated: